GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy InhibitionEloïne Bestion(Aix-Marseille Université), Philippe Halfon(Genoscience Pharma (France))VirusesJanuary 12, 202210.3390/v14010132Cited by 19SaveCiteExport RISWatch citationsRelated PapersGNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functions|Autophagy|2021|84